A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients

Clinical trial NCT03976076 · TERMINATED

Trial details

NCT number: NCT03976076
Sponsor: Bio-Pharm Solutions Co., Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Infantile Spasms

Start date: 2020-04-15
Primary completion: 2021-12-10
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.